California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...

The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...

A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...

Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin ...

Diabetes management has come a long way, and the tools we use are getting smarter. For a long time, it felt like insulin ...

Medtronic’s acquisition of Companion Medical brought a smart insulin pen, the InPen, into its diabetes care lineup.